DrugPatentWatch Database Preview

Loxapine - Generic Drug Details

What are the generic sources for loxapine and what is the scope of loxapine patent protection?

Loxapine is the generic ingredient in five branded drugs marketed by Galen Uk , Teva Branded Pharm, Actavis Labs Ut Inc, Elite Labs Inc, Lannett Co Inc, Mylan, and Watson Labs, and is included in eleven NDAs. There are eighteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Loxapine has two hundred and twenty-five patent family members in twenty countries.

There are eight drug master file entries for loxapine. Two suppliers are listed for this compound.

Summary for loxapine

International Patents:	225
US Patents:	18
Tradenames:	5
Applicants:	7
NDAs:	11
Drug Master File Entries:	8
Suppliers / Packagers:	2
Bulk Api Vendors:	25
Clinical Trials:	23
Patent Applications:	5,394
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for loxapine
DailyMed Link:	loxapine at DailyMed

Medical Subject Heading (MeSH) Categories for loxapine

Antipsychotic Agents
Dopamine Antagonists

Synonyms for loxapine

13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,9,12,14-heptaene
13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene
1977-10-2
2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine
2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine
2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine
2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine
2-Chloro-11-(4-methylpiperazino)dibenz[b,f][1,4]oxazepine
2-Chloro-11-(4-methylpiperazino)dibenzo(b,f)(1,4)oxazepine
27833-64-3 (succinate)
3785AH
54810-23-0 (mono-hydrochloride)
8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine
8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,5]benzoxazepine
8-chloro-6-(4-methylpiperazino)benzo[b][1,4]benzoxazepine;succinic acid
977L102
AB00053735_15
AB00053735_16
AC1L1H3Z
AC1Q3ZWR
Adasuve
Adasuve (TN)
AKOS030526111
API0006785
AZ-004
BDBM22871
BPBio1_000226
BRD-K39915878-036-04-6
BRD-K39915878-036-05-3
BRD-K39915878-036-15-2
BRN 0626753
BSPBio_000204
BSPBio_003479
C07104
C18H18ClN3O
CCG-204805
CHEBI:50841
CHEMBL831
CL 62,362
CL 62362
CL-62362
CL-71,563
CL-71563
CL71,563
Cloxazepine
CS-1105
D02340
DB00408
Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-
Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-
Dibenzacepin
Dibenzoazepine
DivK1c_006919
DTXSID7023229
EINECS 217-835-3
GTPL205
HF 3170
HF3170
HSDB 3111
HY-17390
Hydrofluoride 3170
KBio1_001863
KBio2_000835
KBio2_003403
KBio2_005971
KBio3_002983
KBioSS_000835
L001085
LER583670J
Lopac0_000720
Lossapina
Lossapina [DCIT]
Loxapac
Loxapin
Loxapina
Loxapina [INN-Spanish]
Loxapine (DMSO)
Loxapine (USAN/INN)
Loxapine (water)
Loxapine [USAN:BAN:INN]
Loxapine [USAN:INN:BAN]
Loxapinsuccinate
Loxapinum
Loxapinum [INN-Latin]
Loxepine
Loxitane
LOXITANE C
Loxitane IM
Loxitane Intramuscular
Loxitane-C Oral Suspension
LS-61562
LW 3170
NCGC00021145-01
NCGC00021145-02
NCGC00021145-03
NCGC00021145-04
NCGC00021145-05
NCGC00021145-06
NCGC00021145-07
NCGC00021145-08
NCGC00022279-03
NCGC00022279-04
NCGC00022279-05
Oxilapine
PDSP1_001058
PDSP2_001042
Prestwick0_000132
Prestwick1_000132
Prestwick2_000132
Prestwick3_000132
QTL1_000050
S 805
S-805
SCHEMBL94146
SPBio_001814
SPBio_002143
SpecPlus_000823
Spectrum_000355
Spectrum2_001737
Spectrum3_001830
Spectrum5_001857
Staccato loxapine
SUM 3170
SUM-3170
UNII-LER583670J
W-5098
XJGVXQDUIWGIRW-UHFFFAOYSA-N
ZINC19796158

US Patents and Regulatory Information for loxapine

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lannett Co Inc	LOXAPINE SUCCINATE	loxapine succinate	CAPSULE;ORAL	090695-004	Sep 26, 2011	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Mylan	LOXAPINE SUCCINATE	loxapine succinate	CAPSULE;ORAL	076762-002	Nov 1, 2004	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Galen Uk	ADASUVE	loxapine	POWDER;INHALATION	022549-001	Dec 21, 2012		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Galen Uk	ADASUVE	loxapine	POWDER;INHALATION	022549-001	Dec 21, 2012		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Teva Branded Pharm	LOXITANE	loxapine succinate	TABLET;ORAL	017525-008	Approved Prior to Jan 1, 1982		DISCN	Yes	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Lannett Co Inc	LOXAPINE SUCCINATE	loxapine succinate	CAPSULE;ORAL	090695-003	Sep 26, 2011	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

International Patents for loxapine

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration
Australia	2002364508	➤ Sign Up
Australia	2003295823	➤ Sign Up
Germany	60236430	➤ Sign Up
Austria	404173	➤ Sign Up
Japan	4578772	➤ Sign Up
Germany	60231611	➤ Sign Up
Country	Patent Number	Estimated Expiration

Supplementary Protection Certificates for loxapine

Subscribe to access the full database, or try a Free Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1389098	1390040-2	Sweden	➤ Sign Up	PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001 20130220
1389098	473	Finland	➤ Sign Up
1389098	CA 2013 00046	Denmark	➤ Sign Up	PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001-002 20130220
1389098	CR 2013 00046	Denmark	➤ Sign Up	PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001-002 20130220
1389098	300609	Netherlands	➤ Sign Up	PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220
1389098	C300609	Netherlands	➤ Sign Up	PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description